Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Visualizing Single-Stranded DNA During DNA Repair for Therapeutic Insights
Published on: December 22, 2023
ESRP1 Induces Cervical Cancer Cell G1-Phase Arrest Via Regulating Cyclin A2 mRNA Stability
Zhi-Hong Chen1,2, Ya-Jie Jing3, Jian-Bo Yu4
1School of Basic Medicine, Youjiang Medical University for Nationalities, No. 98 Chengxiang Road, Baise 533000, China. chenzh808@126.com.
Abstract:
Accumulating evidence indicates that epithelial splicing regulatory protein 1 (ESRP1) can inhibit the epithelial-to-mesenchymal transition (EMT), thus playing a central role in regulating the metastatic progression of tumors. However, it is still not clear whether ESRP1 directly influences the cell cycle, or what the possible underlying molecular mechanisms are. In this study, we showed that ESRP1 protein levels were significantly correlated with the Ki-67 proliferative index (r = -0.521; p < 0.01), and that ESRP1 overexpression can significantly inhibit cervical carcinoma cell proliferation and induced G1-phase arrest by downregulating cyclin A2 expression. Importantly, ESRP1 can bind to GGUGGU sequence in the 3'UTR of the cyclin A2 mRNA, and ESRP1 overexpression significantly decreases the stability of the cyclin A2 mRNA. In addition, our experimental results confirm that ESRP1 overexpression results in enhanced CDC20 expression, which is known to be responsible for cyclin A2 degradation. This study provides the first evidence that ESRP1 overexpression induces G1-phase cell cycle arrest via reducing the stability of the cyclin A2 mRNA, and inhibits cervical carcinoma cell proliferation. The findings suggest that the ESRP1/cyclin A2 regulatory axis may be essential as a regulator of cell proliferation, and may thus represent an attractive target for cervical cancer prevention and treatment.
Insights
Epithelial splicing regulatory protein 1 (ESRP1) inhibits cervical cancer cell proliferation by reducing cyclin A2 mRNA stability, leading to G1-phase cell cycle arrest. This ESRP1/cyclin A2 pathway is a potential target for cervical cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Epithelial splicing regulatory protein 1 (ESRP1) is known to inhibit epithelial-to-mesenchymal transition (EMT) and regulate tumor metastasis.
- The direct influence of ESRP1 on the cell cycle and its underlying molecular mechanisms remain unclear.
Purpose of the Study:
- To investigate whether ESRP1 directly affects the cell cycle in cervical carcinoma.
- To elucidate the molecular mechanisms by which ESRP1 influences cell proliferation and cell cycle progression.
Main Methods:
- Correlation analysis between ESRP1 protein levels and Ki-67 proliferative index.
- Assessment of ESRP1's effect on cervical carcinoma cell proliferation and cell cycle distribution (G1 arrest).
- Investigation of ESRP1's impact on cyclin A2 mRNA stability and expression, and its binding to cyclin A2 mRNA 3'UTR.
- Analysis of CDC20 expression in response to ESRP1 overexpression.
Main Results:
- ESRP1 protein levels negatively correlated with the Ki-67 proliferative index (r = -0.521; p < 0.01).
- ESRP1 overexpression inhibited cervical carcinoma cell proliferation and induced G1-phase arrest.
- ESRP1 binds to the GGUGGU sequence in the 3'UTR of cyclin A2 mRNA, decreasing its stability.
- ESRP1 overexpression enhanced CDC20 expression, promoting cyclin A2 degradation.
Conclusions:
- ESRP1 overexpression induces G1-phase cell cycle arrest by reducing cyclin A2 mRNA stability.
- ESRP1 inhibits cervical carcinoma cell proliferation through the ESRP1/cyclin A2 regulatory axis.
- The ESRP1/cyclin A2 axis represents a potential therapeutic target for cervical cancer prevention and treatment.
More Related Videos
Related Concept Videos
Regulated mRNA Transport
Regulated mRNA Transport
Negative Regulator Molecules
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
mRNA Stability and Gene Expression
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

